Index Catalog // ScholarsArchive@OSU

Creator:: Hunter, Barbara G., Duesterdieck-Zellmer, Katja F., and Larson, Maureen K.
Abstract:: Anecdotal accounts of tiludronate administration via intravenous regional limb perfusion (IVRLP) exist despite a lack of information regarding safety for synovial structures in the perfused area. The objective of this study was to determine whether tiludronate concentrations in synovial structures after IVRLP with low dose (0.5 mg, LDT) or high...
Full Text:: findings in synovial fluid after intravenous regional limb perfusion with tiludronate in horses

Creator:: Hunter, Barbara G., Duesterdieck-Zellmer, Katja F., and Larson, Maureen K.
Abstract:: Anecdotal accounts of tiludronate administration via intravenous regional limb perfusion (IVRLP) exist despite a lack of information regarding safety for synovial structures in the perfused area. The objective of this study was to determine whether tiludronate concentrations in synovial structures after IVRLP with low dose (0.5 mg, LDT) or high...
Full Text:: T4 T5 cytology data Horse Time Limb Joint Treatment Blood

Creator:: Hunter, Barbara G., Duesterdieck-Zellmer, Katja F., and Larson, Maureen K.
Abstract:: Anecdotal accounts of tiludronate administration via intravenous regional limb perfusion (IVRLP) exist despite a lack of information regarding safety for synovial structures in the perfused area. The objective of this study was to determine whether tiludronate concentrations in synovial structures after IVRLP with low dose (0.5 mg, LDT) or high...
Resource Type:: Article

ScholarsArchive@OSU